StockData
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31

Anixa Biosciences Inc

Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$2.61−0.06 (-2.25%)

Close on Oct 19, 2026

Market cap
$89.22M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Anixa Biosciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Anixa Biosciences filed with the SEC